BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health. Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities. Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options. About Corporate Groups It takes a village, and at BioMarin our corporate groups are the people behind our success. Groups such as IT, Finance, Legal, Global Compliance & Ethics, and our People Team provide foundational support of all areas of operation at BioMarin. BioMarin has experienced substantial growth organically since its inception, primarily over the last decade. This steady growth in both cost structure and staff was essential to BioMarin’s emergence as a leading, fully integrated global biopharmaceutical company with approximately $3 billion in revenues from over 80 countries, a robust R&D pipeline, operating profits, and world-class technical capabilities through its 3,000 employees worldwide. As the company grows, BioMarin leadership desires to optimize the efficiency of its operations for the future through its next phase of growth. In 2022 BioMarin launched its Enterprise Resource Planning (ERP) enterprise-wide operational initiative transforming the way we work by implementing an ERP system solution, SAP S4 HANA. In Q1, 2025 our first five legal entities went live in SAP, the remaining entities went live in Q1, 2026. Implementing and sustaining a new ERP impacts the entire company The project team is built around the Global Process Workflows as outlined below: Record to Report Order to Cash Source to Pay Plan to Produce Inventory to Deliver Forecast to Plan Enterprise Asset Management SAP Source to Pay Business Process Lead – Source to Pay (STP) Workstream Overview: We are on a procurement transformation journey — advancing our Source to Pay (S2P) maturity and expanding our global Ariba/SAP implementation. As the S2P System & Process Lead for contracting to purchase orders, you’ll be the go-to expert ensuring that Ariba interactions are optimized, processes are streamlined, and best-in-class practices are embedded across our organization. This is a hands-on, change-driving position designed for someone eager to shape the next phase of our global procurement evolution.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level